Inhibrx Announces Details of Presentation at 2022 ASCO Annua

/PRNewswire/ -- Inhibrx, Inc. (Nasdaq: INBX), a biotechnology company with four clinical programs in development and an emerging pre-clinical pipeline,...

Related Keywords

Illinois , United States , Chicago , American , Santp Chawla , Bristol Myers Squibb , Prnewswire Inhibrx Inc , American Society Of Clinical Oncology , European Union , Inhibrx Inc , Nasdaq , Clinical Oncology , Annual Meeting , Exhibit Hall , Fast Track , Orphan Drug Designation , Media Contact , Inhibrx , Nc ,